What You Should Know
- Global healthcare consulting and services leader Tegria has announced the appointment of Craig Mengert as Chief Executive Officer, effective immediately.
- Mengert succeeds Brian Cahill, who is retiring after a 47-year career and transitioning to serve as an independent director on Tegria’s Board of Directors.
- The executive transition follows Tegria’s recent acquisition by Altaris, LLC, a healthcare-dedicated private equity firm focused on tech modernization and operational cost containment.
- Mengert brings over 30 years of enterprise healthcare domain expertise, highlighted by his recent tenure as CEO of Cognizant’s TriZetto, where he managed a $1 billion P&L with 44% operating margins.
- At TriZetto, Mengert spearheaded an aggressive agentic AI strategy, driving double-digit organic growth by embedding automated orchestration layers like the “TriZetto Assistant” to streamline complex prior authorizations and claims workflows.
Leveraging a $1B Turnaround Blueprint and Payer-Provider Fluency
Mengert’s appointment brings a highly specialized operational blueprint to Tegria. His more than 30 years of healthcare technology experience is highlighted by his recent tenure as CEO of TriZetto, a Cognizant subsidiary that manages some of the most critical transaction portfolios in the U.S. healthcare system. Inheriting an organization facing negative growth, Mengert engineered a major corporate turnaround, driving the company to sustained double-digit organic growth exceeding 14% year-over-year. Crucially, he managed a massive $1 billion P&L while maintaining operating margins over 44%, proving a rare ability to align cutting-edge innovation with strict financial discipline.
A defining feature of Mengert’s strategy is his focus on “governance before autonomy”—responsibly deploying advanced technology within highly regulated clinical environments. At TriZetto, he championed the deep integration of artificial intelligence across all core platforms, pioneering agentic software solutions like the “TriZetto Assistant” to automate complex administrative workflows.
Furthermore, his historical background—which began with over a decade managing core IT strategy and cost-reduction initiatives at Horizon BlueCross BlueShield of New Jersey—gives him an authentic understanding of the payer side of healthcare. For a comprehensive services firm like Tegria, which sits at the intersection of both provider and payer ecosystems, this dual-sided operational fluency is invaluable for breaking down traditional data barriers.
“Tegria is a leading healthcare consulting firm delivering industry-recognized services,” Mengert stated. “The firm’s success is driven by a global team of more than 1,000 professionals who are dedicated to the provider and payer clients they serve. I am honored to step into the role of CEO to guide the firm’s next chapter.”
Capitalizing on the Altaris Advantage to Eradicate Infrastructure Debt
The timing of Mengert’s appointment aligns perfectly with Tegria’s recent acquisition by Altaris, LLC, a healthcare-dedicated private equity firm. Altaris doesn’t operate as a passive investor; instead, it takes controlling positions in healthcare enterprises positioned to strip out systemic waste, automate administrative overhead, and actively lower the total cost of care delivery.
The backing of Altaris provides Tegria with a fortified balance sheet and the capital flexibility required to aggressively scale its AI implementation services, invest in deep clinical research, and pursue vertical acquisitions. Rather than forcing cash-strapped hospital networks or regional health plans into uncoordinated software investments, Tegria under Mengert’s leadership is positioned to help clients modernize legacy technology infrastructures, streamline core operations, and achieve measurable financial returns on investment (ROI). Outgoing CEO Brian Cahill will preserve this strategic continuity by remaining on the Board of Directors as an independent director, ensuring his extensive industry knowledge stays embedded within the firm’s forward-looking roadmap.
